UCB
R. Paul Maguire is an experienced professional in clinical imaging, currently serving as the Head of Clinical Imaging and Senior Director at UCB since March 2017, where responsibilities include overseeing scientific strategy and execution in the Neuroscience and Immunology/Bone portfolio. Prior to UCB, R. Paul Maguire held various leadership roles in imaging at Novartis from July 2008 to February 2017, including Director of Imaging and Head of Clinical Imaging, focusing on biomarker development and neuroimaging across Phases I-IV. R. Paul Maguire's career began at Pfizer, where responsibilities included neuroimaging delivery and the development of imaging biomarkers from March 2004 to June 2008. Earlier experience includes positions as a Medical Physicist at UMCG and Rijksuniversiteit Groningen, and a Physicist at the Paul Scherrer Institute. R. Paul Maguire obtained a PhD in Positron Emission Tomography from the University of Surrey between 1993 and 2000.
This person is not in any teams
This person is not in any offices
UCB
47 followers
Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology.